Imerge (Imetelstat) – Clinical Trial Open to Recruitment

Research FOR Patients
-For an informed and empowered opinion-

All the trials listed in our site have been properly vetted for scientific accuracy. Many thanks to Dr Simone Green – Hull and East Yorkshire Hospitals NHS Trust - for the continuous work in updating the listing.

Imerge (Imetelstat)

  1. SUB-TYPE OF MDS: Low risk MDS patients
  2. SEVERITY OF MDS: IPSS Low or Intermediate-1 risk MDS
  3. NAME OF DRUG: Imetelstat
  4. Aims and benefits: This phase 2/3 study aims to determine the effectiveness of Imetelstat in transfusion dependent low risk MDS patients who have either lost their response or not responded to erythropoiesis-stimulating agent (ESA) treatment. The study has 2 parts. Part 1 seeks to determine the effectiveness and safety of Imetelstat, looking more closely at improvement in blood counts and reduction in transfusion requirements. Part 2 is double-blind and randomised to compare the effectiveness of Imetelstat with placebo.
  5. Primary outcome:To determine the percentage of patients who have not required a red cell transfusion in an 8 week period.
  6. Secondary outcome:To determine adverse effects, red cell transfusion independence, improvement in blood counts, progression to acute myeloid leukaemia and overall survival.

  1. Basic inclusion criteria:
    • Diagnosis of MDS with IPSS Low or Intermediate-1 risk
    • Red blood cell transfusion dependent
    • ECOG performance status 0, 1 or 2
  2. Basic exclusion criteria:
    • Received and investigational drug or device within 30 days of study entry or enrolled in an investigational study
    • Prior treatment with Imetelstat
    • Prior treatment with a hypomethylating agent, Lenalidomide, an erythropoiesis-stimulating agent (ESA) or any chemotherapy, immunomodulatory, or immunosuppressive therapy within 4 weeks prior to study entry
  3. Trial sites/locations and name of physician in charge of trial (none are currently recruiting):
    • Nottingham University Hospitals NHS Trust
    • Aberdeen Royal Infirmary
    • The Leeds Teaching Hospitals NHS Trust
    • Guy's Hospital, London
    • Southampton University Hospital

Please read information and always discuss trial information with your own physician.

Free donations by shopping

Sign-up to Download our Free Patient Handbook!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

MDS UK Patient Support Group will use the information you provide on this form to be in touch with you and to provide updates.